How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing Control
Pharma is not failing at digital transformation. It is failing at thinking about complexity.
Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.
This book explains why and what to do instead.
Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.
Inside, you’ll discover:
"synopsis" may belong to another edition of this title.
Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.
Paperback. Condition: new. Paperback. How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing ControlPharma is not failing at digital transformation. It is failing at thinking about complexity.Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.This book explains why and what to do instead.Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.Inside, you'll discover: Why most AI and digital programs stall or quietly increase riskHow GMP authority can remain fully human while intelligence scales safelyWhy documentation, not equipment, is the highest ROI transformation leverHow quality becomes lighter, not weaker, when intelligence is introduced correctlyWhat regulators actually care about (and what they don't)Why intelligence, not size, will determine which pharma companies surviveThis book does not promote automation of decisions. It does not advocate regulatory shortcuts.It does not sell tools, vendors, or frameworks. It offers something far rarer: clarity. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9798246742549
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Print on Demand. Seller Inventory # I-9798246742549
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9798246742549
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9798246742549
Quantity: Over 20 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Neuware - How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing ControlPharma is not failing at digital transformation. It is failing at thinking about complexity.Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.This book explains why and what to do instead.Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.Inside, you'll discover: - Why most AI and digital programs stall or quietly increase risk- How GMP authority can remain fully human while intelligence scales safely- Why documentation, not equipment, is the highest ROI transformation lever- How quality becomes lighter, not weaker, when intelligence is introduced correctly- What regulators actually care about (and what they don't)- Why intelligence, not size, will determine which pharma companies surviveThis book does not promote automation of decisions. It does not advocate regulatory shortcuts.It does not sell tools, vendors, or frameworks. It offers something far rarer: clarity. Seller Inventory # 9798246742549
Quantity: 2 available
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. How CEOs and Quality Leaders Navigate AI, GMP, and Complexity Without Losing ControlPharma is not failing at digital transformation. It is failing at thinking about complexity.Despite massive investment in AI, automation, and digital initiatives, most pharmaceutical organizations feel heavier, slower, and more fragile than ever. Quality systems are overloaded. Experts are exhausted. Leaders carry increasing risk with diminishing visibility.This book explains why and what to do instead.Written for CEOs, board members, senior quality leaders, and manufacturing executives, this is not a technology book. It is a leadership and system-intelligence guide for regulated environments where mistakes are not an option.Inside, you'll discover: Why most AI and digital programs stall or quietly increase riskHow GMP authority can remain fully human while intelligence scales safelyWhy documentation, not equipment, is the highest ROI transformation leverHow quality becomes lighter, not weaker, when intelligence is introduced correctlyWhat regulators actually care about (and what they don't)Why intelligence, not size, will determine which pharma companies surviveThis book does not promote automation of decisions. It does not advocate regulatory shortcuts.It does not sell tools, vendors, or frameworks. It offers something far rarer: clarity. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9798246742549
Quantity: 1 available